WSJ : A New Strain of HIV Is Recorded Under Group That Caused Pandemic

A New Strain of HIV Is Recorded Under Group That Caused Pandemic
Latest strain was found in just three people


Scientists using advanced DNA sequencing technology have documented a previously unidentified strain of HIV under the group that is responsible for the vast majority of human infections.

The previous strain in that group was documented in 2000.

The latest strain was found in just three people, but the findings by Abbott Laboratories ABT 0.15% —a maker of HIV tests—are expected to strike up a broader conversation about how to classify new viral strains that could surface. The company described its findings on Wednesday in an academic journal.

Strains from Group M are the most common in humans and are responsible for the global AIDS pandemic. M strains have infected about 90% of the 37.9 million people that the World Health Organization estimated were living with HIV last year. Group O, N and P infections are rare but can also affect humans.

Wednesday’s Abbott Labs findings have established a 10th group M strain. The three people who are known to carry it live in what is now the Democratic Republic of Congo, where the first HIV infection surfaced in a human in the mid-1900s. Decades later, the virus spread rapidly around the globe.


Two samples of the L strain were detected in the Democratic Republic of Congo in 1983 and 1990. A third suspected sample was found by an Abbott partner hospital there in 2001. But sequencing technology at the time made it hard for company scientists in Illinois, where the sample was shipped, to read it accurately.

“So this sample just sat in our fridge for years, waiting to be unlocked,” said Mary Rodgers, Abbott’s principal scientist and one of the authors of Wednesday’s report.

It was only in recent years, with the falling cost of DNA sequencing and the emergence of so-called next generation sequencing technology, that Abbott scientists were able to isolate the viruses in the sample and read them.

“What we were able to do is basically take a magnet and pull out the virus part of it,” said Dr. Rodgers. The analysis confirmed the sample matched the unusual strain found in 1983 and 1990.

Abbott doesn’t plan to offer a new diagnostic test based on the discovery, but will make the DNA sequence of the new strain public so researchers can study it. Dr. Foley says the Los Alamos National Laboratory plans to add “L” as a new strain in its database.

The finding is prompting a rethink of guidelines surrounding HIV. When they were established in 1999, Dr. Foley says, decoding an entire genome was rare and the cost of sequencing was high.

“One of the things we’re going to talk about next year is should you need, say, 30 samples instead of three to count as a new strain?” he said. Dr. Foley is part of the committee that sets the rules.

Another challenge for the committee is naming new strains. The 10 Group M strains are denoted by letters, while letters O, N and P denote other HIV groups.

Either way, researchers say they will continue looking.

“There’s a lot out there that we don’t know. This is really the tip of the iceberg,” said Abbott’s Dr. Rodgers.

FT : China and the US should prepare for an era of ‘co-opetition’

China and the US should prepare for an era of ‘co-opetition’
The countries must maintain a mutually beneficial collaboration while managing a benign rivalry

The rapid downward slide of China-US relations has exceeded everyone’s expectations. Even I, who was quite pessimistic, did not foresee this nose dive. If one talks about China in Washington now, the atmosphere can best be described as paranoid.

Less than a year after President Donald Trump took office, Washington declared that the US had entered an era of “great power competition” with China as its top strategic rival. The US has taken steps big and small to bash China on trade, technology and student and personnel exchanges. It has also shifted military resources towards the western Pacific, targeting China while pressuring its allies to take the American side as it provokes tension. As for China, though it has not given up its long-held policy of co-operation, it has to fight back against the bullying fists.

Since the end of the cold war, China and the US have headed in different directions. China believes the world, having endured two world wars and a long cold war, is turning to development in a peaceful environment. China has followed this trend; it has reformed and opened up its economy and concentrated on growth. It is now the world’s second-largest economy with a global network of partners. Its participation and influence in international affairs have also grown.

In contrast, the US sought to preserve American hegemony and has endeavoured to mould other countries in ways it preferred. It has waged a series of wars and overstretched its power. The 2008 financial crisis aggravated its domestic problems and caused a decline in the quality of life for its middle class, who have yet to fully recover. American society is in the midst of a soul-searching self-examination, but some are taking the easier path of scapegoating China. American attempts to suppress China’s rise are causing global uncertainty.

The challenge now is for China and the US to handle the fractures in their relationship within the existing international system. Their choices will determine the future of humanity in the 21st century. To achieve a win-win result, both sides must accept that neither can gain all and there has to be give and take.

How does Beijing hope to shape its relationship with Washington? My observation is that China has been trying to maintain its co-operative relations with the US. Thanks to China’s proposal, Presidents Trump and Xi Jinping reaffirmed bilateral relations focused on stability, co-ordination and co-operation after meeting in Osaka in June. Trade talks have restarted.

Looking ahead, I see three scenarios. First, after ironing out the kinks, China and the US should find a new model for interaction that I would dub “co-opetition”: maintaining necessary, mutually beneficial co-operation while managing unavoidable but benign competition.

This relatively ideal scenario would require lots of effort from both sides. As the Chinese saying goes, “the trees prefer calm, but the wind will not cease”. The second scenario is full confrontation. There are forces in US policy circles determined to push this direction. Their ability to influence policy and public opinion is growing strong. They are already trying to decouple the countries as a prelude to confrontation.

The third scenario is the state we are in: drifting. This allows each country to delay its final strategic choice, giving it time to observe and judge the other side more calmly. The challenge lies in ensuring emerging problems are handled in a measured way.

The US appears to believe strongly that China is seeking global dominance and sees their rivalry as a battle it can’t afford to lose. This is a serious misinterpretation. In China, many believe that the US intends to stop China’s development and prevent its people from achieving their hopes for better lives. In this view, China has to resolutely fight back because it cannot allow anyone to forestall its people’s pursuit of happiness, livelihood and national prosperity.

It must be noted that China has never said its policy is to seek global supremacy or that it wants to take over the US role. Our path has been one of peaceful development; and our fight is for the legitimate and equal right to development.

The challenge for the future of China-US relations lies in whether the two can find ways to coexist in the same international system and resolve their differences. If they move towards confrontation, that may lead to the tearing apart of the world. To prevent such a prospect, the other countries also have an important role to play.

President Xi has proposed “building a community with a shared future” and promoting international relations featuring mutual respect, fairness, justice and co-operation. This idea is rooted in Chinese political and cultural wisdom and is consistent with the global trend and common interests of all. It is also the right direction for China-US relations.

The writer, China’s former vice-minister for foreign affairs, chairs Tsinghua University’s International Security and Strategy Centre

>>> US Gapping up

Gapping up 
In reaction to strong earnings/guidance:
  • INGN +14.6%, SQNS +12.3%, CECE +12%, WLH +10.9%, CCRN +10.1%, BLMN +9.8%, STKL +8.9%, PAYS +8.4%, FIVN +8.2%, MRSN +8.1%, CYBR +7.7%, KTOS +6.6%, DVA +6.3%, EVH +6.3%, EVRI +5.9%, HCR +5.6%, HZNP +5.5%, AVLR +5.4%, ICHR +5%, CVIA +4.8%, AES +4.7%, COTY +4.3%, DVN +3.5%, ENBL +3.5%, WEN +3.4%, PODD +3.3%, SSRM +3.2%, PZZA +3.2%, LC +3.1%, PERI +3.1%, IONS +3.1%, TSLX +2.8%, HUM +2.8%, ADAP +2.7%, ODP +2.7%, TGLS +2.7%, ACHV +2.5%, CVS +2.5%, SCOR +2.4%, JAZZ +2.2%, GPRE +2.1%, GOLD +2%, CNR +1.9%, CRCM +1.6%, MYGN +1.6%, GTES +1.3%, PTLA +1.3%, GLMD +1.1%, BCRX +1%

M&A news:

  • AYR +16.1% (to be acquired by a newly-formed entity controlled by affiliates of Marubeni Corporation for $32.00/share in cash)

Other news:

  • SESN +17.3% (reached agreement with the FDA that the post-marketing confirmatory trial for Vicinium will enroll BCG-refractory patients who have received less-than-adequate BCG)
  • WBA +1.5% (after closing 2.6% higher on the day on PE speculation)
  • ABR +1.3% (commences $215 mln private placement of Convertible Senior Notes due 2022)

Analyst comments:

  • BPMC +3.5% (upgraded to Strong Buy from Outperform at Raymond James)
  • LOW +1.2% (upgraded to Outperform from Neutral at Credit Suisse)
  • LULU +1.1% (initiated with Strong Buy at Raymond James)
  • NKE +0.6% (initiated with Outperform at Raymond James)

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance:
  • FLDM -29.2%, SUPN -28.3% (also reports Phase III P301 trial in patients 6 to 11 years old did not meet primary endpoint), PLT -26.2%, VGR -24.2% (announces decision to reduce quarterly cash dividend to $0.20/share, effective in the first quarter of 2020), AMRX -23%, SWIR -18.9%, WW -15.5%, LL -14.7%, ATUS -14.1%, GWPH -12.5%, VG -12.5%, FANG -12.3%, MTCH -11.7%, WLL -10.4%, FRGI -9.6%, GTE -9.4%, CENX -8.5%, LTHM -7%, HUBS -6.5%, RRGB -6.2%, COHR -5.2%, VMC -5%, MODN -4.9%, RRR -4.9%, MCHP -4.5%, OPK -4.5%, ELAN -3.4%, FATE -3.2%, CPS -3.1%, SMG -3.1%, CPRI -2.9%, KELYA -2.9%, BR -2.8%, NEWR -2.7%, PRMW -2.7%, ABUS -2.7%, CARS -2.5%, OMI -2.3%, VER -2%, PE -1.9%, BEAT -1.7%, RGNX -1.6%, TWO -1.5%, AKCA -1.3%, IPHS -1.3%, PRGO -1.2%, ESPR -1.2%, MDGL -1%

Other news:

  • MNK -4.5% (discloses August receipt of SEC subpoena in 10-Q)
  • ZYME -1.3% (enters into $75 mln Open Market Sale Agreement concurrent with automatic shelf registration statement )
  • MPW -0.9% (prices 50 mln share common stock offering at $18.50 per share)
  • ARGO -0.6% (names Kevin Rehnberg Interim CEO after retirement of Mark Watson effective immediately)

Analyst comments:

  • CTL -3.1% (downgraded to Sell from Neutral at Guggenheim)
  • GRPN -2% (downgraded to Underweight from Neutral at JP Morgan)
  • MOS -0.8% (downgraded to Neutral from Overweight at JP Morgan)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up: SESN +13.6%, CCRN +10.1%, FIVN +9.1%, INGN +8.6%, KTOS +6.4%, DVA +6.3%, EVH +6.3%, EVRI +5.9%, HCR +5.6%, AVLR +5.4%, ICHR +5%, PERI +5%, PAYS +4.8%, CVIA +4.8%, AES +4.7%, DVN +3.6%, CVS +3.6%, ENBL +3.5%, PODD +3.3%, SSRM +3.2%, LC +3.1%, TSLX +2.8%, ACHV +2.5%, SCOR +2.4%, HUM +2.1%, VYGR +2%, PTLA +1.8%, CRCM +1.6%, JAZZ +1.4%, WBA +1.3%, GTES +1.3%, CPRI +1.3%, PRGO +1%

  • Gapping down: PLT -27.7%, SUPN -26.2%, FLDM -23.7%, VGR -23%, SWIR -19.3%, AMRX -17.2%, ATUS -13.9%, WW -13.4%, GWPH -12.8%, MTCH -12.5%, FANG -11.1%, FRGI -9.6%, WLL -9.5%, LTHM -9.2%, RRR -7.1%, HUBS -6.5%, RRGB -6.2%, CENX -5.7%, NEWR -5.3%, COHR -5.2%, MODN -4.9%, MCHP -3.5%, CPS -3.1%, LL -2.9%, PE -1.9%, OPK -1.9%, MPW -1.7%, GTE -1.7%, BTG -1.7%, RGNX -1.6%, VER -1.4%, TWO -1.1%

WSJ: XRX considers offer for HPQ


https://www.wsj.com/articles/xerox-considers-takeover-offer-for-hp-11573012201?mod=business_lead_pos1 quick corporate governance (full summary to follow) 4QFY19 EPS due to be reported 11/26

HPQ Restructuring Announcement 10/3/19
Governance Documents

From 10K
Some anti-takeover provisions contained in our certificate of incorporation and bylaws, as well as provisions of Delaware law, could impair a takeover attempt.
We have provisions in our certificate of incorporation and bylaws each of which could have the effect of rendering more difficult or discouraging an acquisition of HP deemed undesirable by our Board of Directors. These include provisions:
authorizing blank check preferred stock, which we could issue with voting, liquidation, dividend and other rights superior to our common stock;

limiting the liability of, and providing indemnification to, our directors and officers;

specifying that our stockholders may take action only at a duly called annual or special meeting of stockholders and otherwise in accordance with our bylaws and limiting the ability of our stockholders to call special meetings;

requiring advance notice of proposals by our stockholders for business to be conducted at stockholder meetings and for nominations of candidates for election to our Board of Directors; and

controlling the procedures for conduct of our Board of Directors and stockholder meetings and election, appointment and removal of our directors.


2019 Annual Meeting 4/23/19

Non staggered board

Board Nominations Deadlines
To nominate a Director for consideration at next year’s annual meeting (but not for inclusion in our annual proxy statement), in general the notice must be received by the Corporate Secretary between the close of business on December 25, 2019 and the close of business on January 24, 2020, unless the annual meeting is moved by more than 30 days before or 60 days after the anniversary of the prior year’s annual meeting, in which case the deadline will be as described in Question 33 above.

In addition, our Bylaws provide that under certain circumstances, a stockholder or group of stockholders may include Director candidates that they have nominated in our annual meeting proxy statement. These proxy access provisions of our Bylaws provide, among other things, that a stockholder or group of up to 20 stockholders seeking to include Director candidates in our annual meeting proxy statement must own 3% or more of HP’s outstanding common stock continuously for at least the previous three years. The number of stockholder-nominated candidates appearing in any annual meeting proxy statement cannot exceed 20% of the number of Directors then serving on the Board. If 20% is not a whole number, the maximum number of stockholder-nominated candidates would be the closest whole number below 20%. Based on the current Board size of 11 Directors, the maximum number of proxy access candidates that we would be required to include in our proxy materials for an annual meeting is two. Nominees submitted under the proxy access procedures that are later withdrawn or are included in the proxy materials as Board-nominated candidates will be counted in determining whether the 20% maximum has been reached. If the number of stockholder-nominated candidates exceeds 20%, each nominating stockholder or group of stockholders may select one nominee for inclusion in our proxy materials until the maximum number is reached. The order of selection would be determined by the amount (largest to smallest) of shares of HP common stock held by each nominating stockholder or group of stockholders. The
Requests to include stockholder-nominated candidates in our proxy materials for next year’s annual meeting must be received by the Corporate Secretary:
not earlier than the close of business on November 25, 2019; and
not later than the close of business on December 25, 2019.

>>> TradeGate Pre-MArket Indications

DAX:
  • Adidas (ADS TH) +1.3%
    • Adidas Earnings Beat Estimates on North America Sales Momentum
  • BMW (BMW TH) +0.3%
    • BMW Earnings Top Estimates on Cost Cuts, Upscale Car Demand
  • BASF (BAS TH) -0.3%
  • Siemens (SIE TH) -0.4%
  • Wirecard (WDI TH) -0.6%
    • Wirecard 3Q Ebitda 1.1% Above Estimates, Sees More Growth in ‘20
  • Deutsche Bank (DBK TH) -0.6%
    • Deutsche Bank NY Bond Trading 5x Average; Clients Net Buyers
  • Daimler (DAI TH) -1.7%
    • Daimler Cut to Reduce at HSBC; PT 45 euros
    • Fourth analyst downgrade this week
MDAX:
  • Evotec SE (EVT TH) +1.6%
    • Evotec, Vifor Pharma in 50:50 JV for Nephrology Therapeutics
  • United Internet (UTDI TH) +1.3%
  • ProSieben (PSM TH) +0.8%
  • Dialog Semi (DLG TH) +0.4%
    • Dialog Semi Beats Estimates in Life After Apple Dependence
  • Qiagen (QIA TH) +0.4%
  • Hochtief (HOT TH) -0.4%
  • K+S (SDF TH) -0.6%
  • Siltronic (WAF TH) -0.6%
  • Evonik (EVK TH) -0.6%
  • Siemens Healthineers (SHL TH) -0.7%
SDAX:
  • Heidelberger Druck (HDD TH) +7.6%
    • Heidelberger Druck Downsizes Board, CTO Plenz to Leave in June
  • Borussia Dortmund (BVB TH) +3.2%
  • HelloFresh (HFG TH) +1.8%
  • SAF Holland (SFQ TH) +0.9%
  • Suedzucker (SZU TH) +0.8%
  • Schaeffler (SHA TH) -0.6%
    • Schaeffler Raised to Buy at Pareto Securities; PT 10.60 euros
  • Aixtron (AIXA TH) -0.9%
  • Steinhoff (SNH TH) -1.3%
  • RIB Software (RIB TH) -1.5%

>>> Stoxx Pre-Market Indication

  • Hannover Re (HNR1 TH) +2.1%
    • Hannover Re Raises 2019 Net Guidance, Sees 2020 of About EU1.2b
  • Evotec SE (EVT TH) +1.3%
    • Evotec, Vifor Pharma in 50:50 JV for Nephrology Therapeutics
  • Adidas (ADS TH) +1.1%
    • Adidas Earnings Beat Estimates on North America Sales Momentum
  • BMW (BMW TH) +0.7%
    • BMW Earnings Top Estimates on Cost Cuts, Upscale Car Demand
  • Brenntag (BNR TH) +0.6%
    • Brenntag Narrows FY Op. Ebitda Growth to Low End Range
  • United Internet (UTDI TH) +0.6%
  • ProSieben (PSM TH) +0.6%
  • Erste (EBO TH) -0.8%
  • Siemens Healthineers (SHL TH) -0.9%
  • TUI (TUI1 TH) -1%
  • Evonik (EVK TH) -1%
    • Evonik at Non-Deal Roadshows Hosted By Berenberg and Kepler Today
  • Immofinanz (IMO1 TH) -1.2%
  • Red Electrica (RE21 TH) -1.2%
  • Daimler (DAI TH) -1.4%
    • Daimler Cut to Reduce at HSBC; PT 45 euros
    • Fourth analyst downgrade this week
  • Verbund (OEWA TH) -1.6%
    • Verbund Third Quarter Net Income Misses Estimates
  • Voestalpine (VAS TH) -1.8%
    • Voestalpine Cuts Outlook for Third Time, Reviews All Units
  • SocGen (SGE TH) -2.3%
    • SocGen Equities Trading Slumps 20% in Blow to Oudea’s Revamp

FT : Ion: the financial data group taking on Bloomberg

Ion: the financial data group taking on Bloomberg
Andrea Pignataro has bought Mergermarket, Fidessa and Dealogic in a debt-fuelled spree

In 1999, Andrea Pignataro followed in the footsteps of Michael Bloomberg: leaving the cut and thrust of bond trading at Salomon Brothers to build a financial data empire.

Like Mr Bloomberg, who left Salomon 18 years before him, Mr Pignataro saw an opportunity to exploit the fact that financial markets were becoming more international and electronic.

He cut his teeth in the Italian sovereign debt market of the 1990s, which had turned to computerised trading earlier than the UK, France or Germany. The realisation that human traders would make way for coders and algorithms led him to build an electronic trading platform.

Since then, he has established his company, Ion Group, as an integral part of the plumbing that underpins the trading of shares, debt and derivatives around the world.

Yet, in stark contrast to Bloomberg, which is a conspicuous presence throughout financial markets, Ion’s profile is intentionally discreet, mirroring the nature of its 49-year-old Italian founder.

Even though Ion has bought 20 companies since 2005, Mr Pignataro’s group, which he runs from offices overlooking St Paul’s Cathedral in London, remains little known outside its specialist markets.

Ion, which declined to comment for this article, has now reached a size that its founder’s fondness of privacy is harder to maintain. And its debt-fuelled acquisitions are prompting more questions about the level of borrowing, the amount of job losses and the degree of dividend payouts.

After completing a £1.5bn deal in 2018 for trading software maker Fidessa and the £1.4bn acquisition of a majority stake in financial news company Acuris earlier this year, Ion is now a mini-conglomerate that spans data and trade processing, and includes brands such as Dealogic and Mergermarket. Its combined enterprise value is about £7bn. Revenues last year were about £830m.

“If you’re trading bonds or swaps, at some point in the overall chain, Ion’s connectivity network will be used,” said Russell Dinnage, head of capital markets at consultancy Greyspark Partners.

Some larger rivals such as Bloomberg, FIS and Intercontinental Exchange compete in parts of Ion’s markets, but none directly rivals Ion across all its markets, where it mostly competes with niche software companies.

Ion’s low profile stems in part from Mr Pignataro’s management style, where information is tightly controlled among a close circle of fewer than 10 advisers, according to those who have met and worked with Mr Pignataro. They describe him as “very driven” and “single-minded”.

People who have met and worked with Mr Pignataro paint a picture of a man who exerts tight control on Ion, with one banker describing him as “a complete round-the-clock workaholic”.

“With his success comes a confidence, some would say arrogance, in his personal judgment,” the person said. “One could say he’s a micromanager, and there’s a big ‘key man’ risk for his whole operation, but I have a positive spin on it.”

Mr Pignataro retains more than 90 per cent of the shares, according to corporate filings, while private equity firm Carlyle acquired a minority stake for $400m in 2016.

Ion has also eschewed public markets for funding, instead relying on private debt to finance its acquisition spree. Although Ion declined to disclose its level of borrowing, loan fund managers said that the overall group now has more than $6bn of debt.

To support these high debt levels, Mr Pignataro is known for taking an unsentimental approach to cutting costs. After acquiring Fidessa, a software maker that supplies trading tools to more than 700 brokers, Ion targeted reducing its combined 3,300-strong workforce by 15-20 per cent to make about $50m in annual savings, according to company filings.

Within acquired companies, the squeeze on investment has left many middle managers and salespeople in the line of fire and unhappy, former employees of companies bought by Ion say.

Some 300-400 senior Fidessa people have voluntarily left in recent months, on top of those in line to be made redundant, according to four former employees. None was willing to discuss Ion publicly.

The loss of experienced employees has raised questions internally over whether quality can be maintained. “Some of these products are complicated,” said one former executive. “You can only charge for a premium product if it has a premium service.”

Lenders, who have been happy to lend to the growing group, have recently started to sound the alarm over the amount of money Mr Pignataro has taken out of the business.

Rating agency Moody’s downgraded Ion Trading, the vehicle that owns Fidessa, more deeply into junk status in September because “the company had paid substantial dividends” instead of paying down debt, taking more than €125m out of the group at the start of 2019 alone.

Ion’s Irish parent company has paid €195m in dividends to entities controlled by Mr Pignataro and Carlyle since the start of 2017.

Mr Pignataro, who owns a home in Belgravia, London, has also developed a luxury estate in St Vincent and the Grenadines that he is trying to turn into the next fashionable upmarket resort

One loan fund manager said he had stopped lending to the group after recent payouts. He added that Ion’s continual acquisitions and frequent corporate reorganisations had made these shareholder distributions harder to track.

“It reminds you of the guy at the fair with three cups and a ball,” he said. “You never know where the ball is.”

In May, Ion’s lenders took a stand, refusing to back a plan for a $2bn debt deal in which Ion would have taken out another $250m dividend. The plan would have rolled together three software businesses — Wall Street Systems, Openlink and, TriplePoint — into a new company called Ion Corporates.

The aborted deal was a black eye for UBS, which has acted as Ion’s sole financial adviser for most of its deals over the past five years, earning the Swiss bank tens of millions in fees.

Mr Pignataro had a close relationship with former investment banking chief Andrea Orcel, according to people familiar with the matter, but Ion’s struggles in the loan market made executives at the Swiss bank nervous since they had just single-handedly underwritten more than $1bn of debt backing the Acuris acquisition.

UBS was ultimately let off the hook. Ion decided instead to raise $1.25bn of financing from credit fund HPS and the private debt division of Goldman Sachs and then turned to Credit Suisse to reboot the Ion Corporates deal last month, successfully raising $1.75bn of debt after agreeing more conservative terms with its lenders.

Like Bloomberg before it, Ion has now reached a size where speculation swirls about its ownership and whether one man can continue to hold it so closely.

“Andrea is this unknown person who has aggregated all these companies globally, essentially with his own money, and he’s amassed a conglomerate, but now what does he do with it?” said one of his longtime bankers. “Is he looking at an IPO or big strategic sale? No one is sure yet what his ultimate strategy is.”

FT : The 3D holographic display machine inspired by Star Wars

The 3D holographic display machine inspired by Star Wars
A company has developed what they say is the first commercially available hologram projector


For the 25 years I have been writing about technology, the prospect of holograms has been floating around like, well, a hologram.

Indeed, even earlier, my 1972 sixth-form general studies project on future technology promised, on the best evidence, that by the 1980s, it would be possible to project a talking hologram of your late grandmother into her favourite chair.

Five years later, a holographic Princess Leia pleaded for help from Obi-Wan Kenobi in the first Star Wars film, yet beyond that, the technology has been a little behind schedule.

But a company working from Flinders University in Adelaide, South Australia, has quietly been developing what they say is the first commercially available hologram projector, and the video and still images it casts are spookily like the Star Wars imaginings.

I watched a 10cm-tall version of a real footballer playing keepy-uppy and was able to move around him to view his movements from all angles. Among the striking demos, I also saw hologrammic versions of CT scans which could be viewed as if you had X-ray eyes.

The $9,800 Voxon VX1 machine, a squat black cube with a 20cm square glass top from which the image is “written” into the air, makes a wheezy chugging noise which definitely was not present in Star Wars, but is still impressive.

The machine’s principle is to laser project 1,400 layers, or slices, of an image simultaneously by a vibrating mechanism and rely on our persistence of vision to see the result as a “real” 3D object.

Early buyers, say makers Voxon Photonics, include Harvard University and MIT, car companies, medical faculties, a major computer games company, advertising agencies and companies mapping the seabed.

At Harvard, one of the applications developed was to look at a dance performance from different angles. A watch company has used it at an exhibition to show the inside of a mechanical watch.

One of the machine’s inventors, Gavin Smith, a Strathclyde University MSc who came to Adelaide from Scotland 12 years ago, admits Star Wars was the inspiration for the Voxon 1.

“I was working in IT and, with my co-founder, got interested in optics and lasers, and were especially intrigued with the idea of making the hologram from Star Wars,” Mr Smith explained. “There are plenty of technologies which create an illusion of an image in space, but nothing that makes true 3D imagery which can be walked around and looked at from any angle without a headset.”

The inventive pair became adept at picking up electronic junk left out for recycling on Adelaide’s streets and using parts from it. They also wrote custom graphics software and in time, produced their first hologram, of a tiny elephant, and put a video on YouTube.


But then they were contacted by a group in the US who had done almost the same, with a tiny holographic dinosaur. They joined forces and got a famous games programmer, Ken Silverman, to write a graphics programme much faster than that needed for a video game.

The company now has 16 employees, and an effective A$1.5m seed-round funding raised in South Australia. They are now looking to raise a further US$10m.

Medicine may be the first area where it starts to be used for real. When doctors show patients CT and MRI scans, they are difficult for a lay person to interpret.

“If the doctor can bring up a walk-around image of your actual bone structure when you’ve broken a limb, you have an understanding of what’s needed — and will also be able to see a scan of a similar break post-operative, with the titanium pins in place, to get a full idea of what’s being done.”

At the other end of the scale, Mr Smith envisions not long from now a new form of entertainment, where you watch a real football match live, in miniature, on a table soccer machine.

On the matter of projecting the late granny into her chair, however, Voxon do not yet have an answer.